News & Blogs | PharpleQ

2 Articles

B2B Partnerships ×

International Pharmaceutical Events Schedule - 2027

by PharpleQ

At PharpleQ Lifesciences, we mitigate these risks by offering comprehensive, asset-light, end-to-end solutions spanning generic and novel pharmaceuticals, nutraceuticals, cosmeceuticals, and veterinar...

Asset Light Pharma B2B Partnerships Business Exhibition Business Partnership CPHI Contract Manufacturing Healthcare Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd. euroPLX

06-Nov-2026

0 32

PharpleQ-Blogs

Blockbuster Drug Patent Recent Expirations (2024–2031) and B2B Generic Licensing Opportunities

by PharpleQ

In the global pharmaceutical industry, the expiration of a molecule’s active compound patent is only the first hurdle. The true gateway to high-margin generic entry is navigating Formulation and Compo...

Asset Light Pharma B2B Partnerships Business Partnership CDMO / CMO Dossier Licensing - In/Out Formulation Engineering Pharma Portfolio Expansion Pharma Sourcing Partnerships PharpleQ PharpleQ Lifesciences Pvt. Ltd.

01-Nov-2026

0 27

PharpleQ-Blogs

PharpleQ lifesciences

Be connected with PharpleQ, to get updated on latest news.

Archives

Tags

Tag

Asset Light Pharma B2B Partnerships Business Exhibition Business Partnership CDMO / CMO CPHI Contract Manufacturing Dossier Licensing - In/Out Formulation Engineering Healthcare India’s Healthcare Market Pharmaceuticals PharpleQ PharpleQ Lifesciences Pvt. Ltd. Project Coordination Quick. Quality. Quorum. Regulatory Compliance Technology Transfer Third-Party Manufacturing euroPLX

Others

BE study monitoring Bioequivalence Studies Commercial Supply Agreement Cosmeceutical Products CRO Collaboration CRO in India Food Supplements Indian CRO Services Nutraceutical Products Pharma Co-Development Pharma Portfolio Expansion Pharma Sourcing Partnerships Therapeutic Nutraceuticals